Trevena to Host Conference Call on March 9th to Discuss Full Year 2015 Financial Results
- Dow falls ahead of Powell speech; Tesla shares boost Nasdaq
- CrowdStrike (CRWD) plunges 20% after 'messy' and 'disappointing' results
- U.S. private payrolls growth slows in November-ADP
- Analysts impressed by Biogen (BIIB) after full data on Alzheimer's drug Lecanemab
- Oil up more than $2 on tighter supply but OPEC+ talks limit gains
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)-- Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company, today announced that it will host a conference call on Wednesday, March 9, 2016 at 7:30 a.m. Eastern Time to discuss financial results as of and for the year ended December 31, 2015, as well as 2015 and recent corporate highlights.
The call can be accessed by dialing (855) 465-0180 (U.S. and Canada) or (484) 756-4313 (international), and entering passcode 63684856.
To access a live audio webcast of the call, please visit the “Investors” section at investors.trevenainc.com. Following the conclusion of the call, the call will be archived and available for replay for 30 days on both the company's website and by dialing (855) 859-2056 (U.S. and Canada) or 404-537-3406 (international), and entering passcode 63684856.
Trevena, Inc. is a clinical stage biopharmaceutical company that discovers, develops and intends to commercialize therapeutics that use a novel approach to target G protein coupled receptors, or GPCRs. Using its proprietary product platform, Trevena has identified four biased ligand product candidates – oliceridine (TRV130) to manage moderate to severe acute pain intravenously (Phase 3), TRV027 to treat acute heart failure (Phase 2b), TRV734 to manage moderate to severe acute and chronic pain orally (Phase 1), and TRV250 for acute migraine and other CNS disorders (preclinical).
Jonathan Violin, Ph.D.
Sr. Director of Investor Relations
Source: Trevena, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 8x8, Inc. (EGHT) Terminates Employment Relationship With CEO Dave Sipes
- RE/MAX Holdings (RMAX) Posts Strong Q3 Franchise Sales, Retention Results
- Seadrill Ltd. (SDRL) Misses Q3 EPS by 22c; Raises Guidance
Create E-mail Alert Related CategoriesPress Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!